For the treatment of type 2 diabetes mellitus in adults:
• As monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.
• As dual oral therapy in combination with:
• Metformin, in patients with insufficient glycemic control despite maximal tolerated dose of
monotherapy with Metformin.
• Sulfonylurea, in patients with insufficient glycemic control despite maximal tolerated dose of a
sulfonylurea and for whom metformin is inappropriate due to contraindications or intolerance.
• Thiazolidinedione, in patients with insufficient glycemic control and for
whom the use of a thiazolidinedione is appropriate.
• As triple oral therapy in combination with Sulfonylurea and Metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycemic control.
• Also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycemic control.